Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Engineering Validation of Leo Device to Assess Clinical Control of Children Recovering From Acute Asthma Exacerbation

NCT05308277 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT05308277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Engineering Validation of Leo Device to Assess Clinical Control of Children Recovering From Acute Asthma Exacerbation
Lead sponsor
ResMed
Phase
Not applicable
Overall status
Unknown status
Start date
April 27, 2022
Completion date
April 30, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children